These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 698976

  • 1. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
    Isaacs JT, Heston WD, Weissman RM, Coffey DS.
    Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
    [Abstract] [Full Text] [Related]

  • 2. Characterization of steroid hormone receptors in the Dunning R-3327 rat prostatic adenocarcinoma.
    Markland FS, Chopp RT, Cosgrove MD, Howard EB.
    Cancer Res; 1978 Sep; 38(9):2818-26. PubMed ID: 679189
    [No Abstract] [Full Text] [Related]

  • 3. Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors.
    Isaacs JT, Isaacs WB, Coffey DS.
    Cancer Res; 1979 Jul; 39(7 Pt 1):2652-9. PubMed ID: 445468
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.
    Isaacs JT, Wake N, Coffey DS, Sandberg AA.
    Cancer Res; 1982 Jun; 42(6):2353-71. PubMed ID: 7074614
    [Abstract] [Full Text] [Related]

  • 7. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
    Quarmby VE, Beckman WC, Cooke DB, Lubahn DB, Joseph DR, Wilson EM, French FS.
    Cancer Res; 1990 Feb 01; 50(3):735-9. PubMed ID: 2404576
    [Abstract] [Full Text] [Related]

  • 8. Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
    Isaacs JT, Weissman RM, Coffey DS, Scott WW.
    Prog Clin Biol Res; 1980 Feb 01; 37():311-23. PubMed ID: 7384091
    [Abstract] [Full Text] [Related]

  • 9. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
    Mobbs BG, Johnson IE.
    Cancer Res; 1988 Jun 01; 48(11):3077-83. PubMed ID: 3259159
    [Abstract] [Full Text] [Related]

  • 10. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE, Isaacs JT.
    Cancer Res; 1982 Aug 01; 42(8):3148-56. PubMed ID: 7093958
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK, Heston WD, Scott WW, Coffey DS.
    Cancer Treat Rep; 1977 Aug 01; 61(2):273-87. PubMed ID: 872132
    [Abstract] [Full Text] [Related]

  • 12. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT, Yu GW, Coffey DS.
    Invest Urol; 1981 Jul 01; 19(1):20-3. PubMed ID: 7251319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sensitive biochemical methods to distinguish hormone dependent and independent Dunning tumors of prostatic origin.
    Chung LW, Thompson TC, Breitweiser K.
    Proc West Pharmacol Soc; 1981 Jul 01; 24():305-10. PubMed ID: 6265951
    [No Abstract] [Full Text] [Related]

  • 16. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
    Coffey DS, Smolev J, Heston WD, Scott WW.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):289-91. PubMed ID: 748782
    [Abstract] [Full Text] [Related]

  • 17. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 18. The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
    Salling LN, Høyer M, Overgaard J.
    Scand J Urol Nephrol Suppl; 1995 May 15; 172():73-9. PubMed ID: 8578260
    [Abstract] [Full Text] [Related]

  • 19. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
    Drago JR, Goldman LB, Maurer RE, Eckels DD, Gershwin ME.
    J Natl Cancer Inst; 1980 Apr 15; 64(4):931-7. PubMed ID: 6929004
    [No Abstract] [Full Text] [Related]

  • 20. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM, Milholland RJ, Rosen F.
    Cancer Res; 1980 Jul 15; 40(7):2188-93. PubMed ID: 7388787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.